Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2020 06:30 ET | Source: Emergent BioSolutions

Emergent BioSolutions Joins U.S. Government’s Warp Speed Program in Landmark Public-Private CDMO Partnership for COVID-19 Vaccine Development and Manufacturing

Emergent and HHS expand 2012 CIADM public-private partnership with task order valued at approximately $628 million for rapid domestic production of leading COVID-19 vaccine candidates through 2021...
May 12, 2020 06:00 ET | Source: Emergent BioSolutions

Emergent BioSolutions to Participate in Virtual Investor Conferences

GAITHERSBURG, Md., May 12, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
May 07, 2020 09:20 ET | Source: Emergent BioSolutions

Emergent BioSolutions to Hold Virtual Annual Meeting of Stockholders on Thursday, May 21, 2020 at 9:00am EDT

GAITHERSBURG, Md., May 07, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that its 2020 Annual Meeting of Stockholders will be held in a virtual-only format via live...
April 30, 2020 16:08 ET | Source: Emergent BioSolutions

Emergent BioSolutions Reports Financial Results for First Quarter 2020

Reaffirms full year 2020 financial forecastExecutes multi-faceted response to COVID-19 drawing upon longstanding investments in capabilities to address public health threats, as well as expertise in...
April 23, 2020 18:51 ET | Source: Emergent BioSolutions

Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19

Emergent will provide contract development and manufacturing services to support Johnson & Johnson’s commitment of one billion doses of vaccine for worldwide emergency pandemic useAgreement valued...
April 21, 2020 16:55 ET | Source: Emergent BioSolutions

Emergent BioSolutions Appoints Dr. Karen L. Smith as Chief Medical Officer

GAITHERSBURG, Md., April 21, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Dr. Karen L. Smith, M.D., Ph.D. as chief medical officer with...
April 16, 2020 06:30 ET | Source: Emergent BioSolutions

Emergent BioSolutions to Release First Quarter 2020 Financial Results and Conduct Conference Call on April 30, 2020

GAITHERSBURG, Md., April 16, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, April 30, 2020 at 5:00 pm (Eastern Time) to discuss the...
April 06, 2020 06:30 ET | Source: Emergent BioSolutions

Emergent BioSolutions Appoints Nina DeLorenzo as Senior Vice President of Global Public Affairs

GAITHERSBURG, Md., April 06, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Nina DeLorenzo to the position of senior vice president for global...
April 02, 2020 16:05 ET | Source: Emergent BioSolutions

Emergent BioSolutions Partners with U.S. Government for Comprehensive Response to Expedite Development of Plasma-Derived Therapy for COVID-19

BARDA to provide $14.5 million in funding to support development of COVID-Human Immune Globulin (COVID-HIG), a human plasma-derived therapy candidate being developed as a potential treatment for...
March 31, 2020 16:05 ET | Source: Emergent BioSolutions

Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™

CDMO agreement for NanoFlu to support pathway to licensureExpanded collaboration now includes NanoFlu and COVID-19 vaccine candidate GAITHERSBURG, Md., March 31, 2020 (GLOBE NEWSWIRE) -- Emergent...